bipolar disorder
After FDA approval, Alkermes plans soft launch for antipsychotic Lybalvi
Phil Taylor
Alkermes, bipolar disorder, FDA approval, Lybalvi, Psychiatry, schizophrenia
0 Comment
BioXcel’s phase 3 schizophrenia film has blockbuster potential, say analysts
Richard Staines
BioXcel, bipolar disorder, mental health, schizophrenia
0 Comment
Allergan and Gedeon Richter set to expand use of bipolar drug
Richard Staines
Allergan, bipolar disorder, depression, Gedeon Richter
0 Comment
Companies want Vraylar as option bipolar depression
Report links Sanofi epilepsy drug with thousands of birth defects
Richard Staines
bipolar disorder, epilepsy, regulation, safety, Sanofi
0 Comment
Depakine and generics linked with defects including spina bifida.
Lundbeck/Otsuka look for new use of mental health drug
Richard Staines
bipolar disorder, schizophrenia
0 Comment
Companies want new bipolar disorder use for Abilify Maintena.